Araçlar ile Ekonomik etkinlikler ile ilgili alarm oluşturmak
ve takip ettiğiniz yazarların yayınları için kayıt olun.
Ücretsiz Kayıt Olun Hesabınız var mı? Giriş Yapın
12,240
+0,070
+0,58%
Kurlar
Tüm Araç Çeşitleri
- Tüm Araç Çeşitleri
- Endeksler
- Hisse Senetleri
- ETF'ler
- Fonlar
- Emtia
- Dövizler
- Kripto Para
- Tahviller
- Sertifikalar
Lütfen başka bir arama deneyiniz
📊 2025’de bizi neler bekliyor? İslam Memiş öngörülerini Investing.com’a özel yazısında paylaştı
Şimdi Okuyun
Blackrock Global Funds - World Healthscience Fund D2 Eur Hedged (0P0001K1IR)
Portföy'e Ekle/Kaldır
Portföye Ekle
23/12 - Kapanış. Döviz EUR
- Morningstar Derecelendirmesi:
- Toplam Varlık: 26,49M
Tür:
Fon
Piyasa:
Lüksemburg
İhraççı:
BlackRock (Luxembourg) SA
ISIN:
LU2168656341
Varlık Sınıfı:
Hisse senedi
BlackRock Global Funds - World Healthscience Fund
12,240
+0,070
+0,58%
- Genel Bakış
- Profil
- Geçmiş Veriler
- Varlıklar
0P0001K1IR Genel Bakış
Bu sayfada Blackrock Global Funds - World Healthscience Fund D2 Eur Hedged hakkında detaylı bir profile ulaşabilirsiniz. Yönetim, toplam varlıklar, yatırım stratejisi, iletişim bilgileri ve 0P0001K1IR için diğer bilgileri görüntüleyin.
İrtibat Bilgisi
Adres
35 A, avenue J.F. Kennedy,
Luxembourg, L-1855
Luxembourg
Luxembourg, L-1855
Luxembourg
Telefon
+44 20 77433000
Faks
Amsterdam
Site
www.blackrock.com
Üst Düzey Yöneticiler
| İsim | Başlık | B.Tarihi | Bitiş |
|---|---|---|---|
| Xiang Liu | Director | 2020 | Şimdi |
| Biyografi | Xiang Liu, PhD, Director, is a member of the Health Sciences team, part of BlackRock’s Active Equity Group. He is co-portfolio manager for the Health Sciences equity portfolios and is responsible for coverage of the medical devices & supplies sector. Prior to joining BlackRock in 2008, Mr. Liu was a partner and biotech analyst at Mehta Partners. From 2002 to 2005, he was a Director in the corporate development department at Cubist Pharmaceuticals. Mr. Liu began his investment career in 2000 at the Boston Consulting Group as a Healthcare consultant. Mr. Liu earned a BS degree in Chemistry from the University of Science & Technology, China in 1993, a PhD degree in Chemistry from Yale University in 1997, and a MBA degree in finance, strategy, and accounting from the University of Chicago in 2000. | ||
| Erin Xie | Managing Director | 2011 | Şimdi |
| Biyografi | Erin Xie, PhD, Managing Director and portfolio manager, is the head of the Health Sciences team, part of BlackRock’s Active Equity Group. She is the lead portfolio manager for the Health Sciences equity portfolios. Ms. Xie's service with the firm dates back to 2001, including her years with State Street Research & Management (SSRM), which merged with BlackRock in 2005. At SSRM, she was a Senior Vice President and portfolio manager responsible for managing the State Street Health Sciences Fund. Prior to joining State Street Research in 2001, Ms. Xie was a research associate with Sanford Bernstein covering the pharmaceutical industry from 1999. From 1994 until 1997, she was a post doctoral research scientist at Columbia University. Ms. Xie earned a BS degree in chemistry from Beijing University in 1988, a PhD degree in Biochemistry from the University of California, Los Angeles, in 1993 and a MBA degree from the Massachusetts Institute of Technology Sloan School of Management in 1999. | ||
| Jeff Lee | - | 2020 | 2023 |
| Biyografi | Jeffrey Lee, Director, is a member of the Health Sciences team, part of BlackRock’s Active Equity Group. He is co-portfolio manager for the Health Sciences equity portfolios and is responsible for coverage of the healthcare providers and services sector. Prior to joining BlackRock in 2011, Mr. Lee was a member of the healthcare investment team at Duquesne Capital Management where he covered provider and service companies. From 2006 to 2008, Mr. Lee was an healthcare private equity associate at Altaris Capital Partners where he sourced and analyzed equity transactions for public and private healthcare companies. Prior to 2006, Mr. Lee was an analyst at Citigroup within the healthcare finance and investment banking group where he valued and helped structured financing for managed care providers, hospital companies and other large healthcare systems. Mr. Lee earned a BA degree in economics, cum laude, from Princeton University in 2004. | ||
| Thomas P. Callan | Managing Director | 2011 | 2017 |
| Biyografi | Thomas P. Callan, CFA, Managing Director and senior portfolio manager, is head of BlackRock's Global Opportunities equity team. He oversees the team's investment process, leads the team's Investment Strategy Group, and provides portfolio and risk management oversight for all of the team's products. In addition, Mr. Callan is a member of BlackRock's Leadership Committee. Mr. Callan's service with the firm dates back to 1988, including his years with PNC Asset Management Group, which was integrated with BlackRock in 1998. He started as a health care analyst for PNC's mutual fund group and later served as an international equity analyst. Mr. Callan began his investment career at PNC Bank as a personal trust portfolio manager in 1988. Mr. Callan earned a BA degree in economics, with honors, from Boston College in 1981. | ||
| Bob Hodgson | - | 2005 | 2011 |
Blackrock Global Funds - World Healthscience Fund D2 Eur Hedged hakkında düşüncelerinizi yazın
Bu grafiği silmek istediğinize emin misiniz?
Sil İptal
Ekteki grafiği yeni bir grafikle değiştirmek istiyor musunuz?
Değiştir İptal
Yorum Kuralları
Yoruma Grafik Ekle
Engellemeyi Onayla
%USER_NAME% isimli kullanıcıyı engellemek istediğinize emin misiniz?
Bunu onayladıktan sonra %USER_NAME% isimli kullanıcı ile birbirinizin yorumlarını görmeyeceksiniz.
%USER_NAME% başarıyla Engelli Listesine eklendi
Bu kişinin engelini yeni kaldırdınız. Yeniden engellemek için 48 saat beklemeniz gerekmektedir.
Yorumu şikayet et
Yorum silinmeli, çünkü:
Yorum Şikayet Edildi
Teşekkürler!
Şikayetiniz yönetim ekibimize iletildi